SAPCD2 and fibrosarcoma: Consistently, our results were further supported by the findings from the fibrosarcoma datasets from TCGA that fibrosarcoma patients with high SAPCD2 expression exhibited poor overall survival and early progression-free survival compared with those with low SAPCD2 expression (Figures 2D, E).